Tag: Prurigo Nodularis

Prurigo nodularis: long-term treatment decreases relapse events

Presented By
Prof. Franz Legat, Medical University Graz, Austria
Trial
Phase 3
Conference
EADV 2024
Type
Peer-reviewed article

6 November 2024 13:47

JAK1 inhibitor shows promising long-term efficacy in PN

Presented By
Dr Shawn Kwatra, Johns Hopkins University School of Medicine, USA
Trial
Phase 2
Conference
EADV 2024
Type
Peer-reviewed article

6 November 2024 13:44

What’s new in clinical dermatology?

Presented By
Dr Tamar Nijsten, Erasmus University Medical Centre, the Netherlands
Conference
DDD 2024
Type
Peer-reviewed article

31 May 2024 13:31

JAK1 inhibitor meets primary endpoint in prurigo nodularis

Presented By
Prof. Martin Metz, Charité University Hospital, Germany
Trial
Phase 2
Conference
AAD 2024
Type
Peer-reviewed article

22 April 2024 15:17

Nemolizumab shows high success rates in prurigo nodularis

Presented By
Prof. Sonja Ständer, Münster University Hospital, Germany
Trial
Phase 3, OLYMPIA 1
Conference
EADV 2023
Type
Peer-reviewed article

28 November 2023 10:19

OLYMPIA 2: Positive results for nemolizumab in prurigo nodularis

Presented By
Prof. Sonja Ständer, University Hospital Münster, Germany
Trial
Phase 3, OLYMPIA 2
Conference
WCD 2023
Type
Peer-reviewed article

31 August 2023 14:59

Nemolizumab decreases lesions and itch in prurigo nodularis

Presented By
Prof. Shawn Kwatra , Johns Hopkins University School of Medicine, MD, USA
Trial
Phase 3, OLYMPIA 2
Conference
AAD 2023
Type
Peer-reviewed article

15 May 2023 10:40

Dupilumab leads to clinically relevant improvements in signs and symptoms of prurigo nodularis

Presented By
Prof. Gil Yosipovitch, University of Miami, FL, USA
Trial
Phase 2, LIBERTY-PN PRIME
Conference
EADV 2022
Type
Peer-reviewed article

5 November 2022 10:59

Nalbuphine: aspiring to become another treatment for prurigo nodularis?

Presented By
Prof. Sonja Ständer, University Medical Centre of Münster, Germany
Trial
Phase 3, PRISM
Conference
EADV 2022
Type
Peer-reviewed article

5 November 2022 10:57

EADV 2022 Highlights Podcast

Presented By
Dr Rachel Giles, Medicom
Conference
EADV 2022

27 September 2022 11:49

Could dupilumab put an end to the therapeutic draught in prurigo nodularis?

Presented By
Prof. Gil Yosipovitch, University of Miami, USA
Trial
Phase 3, LIBERTY-PN PRIME 2
Conference
AAD 2022

17 May 2022 11:59

AAD 2022 Highlights Podcast

Presented By
Dr Rachel Giles, Medicom
Conference
AAD 2022

14 April 2022 11:02
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com